日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Use of Ruxolitinib Cream Results in Economic Benefits Compared with Dupilumab in Treatment of Patients with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy

与度普利尤单抗相比,使用鲁索替尼乳膏治疗符合全身治疗严重程度阈值的特应性皮炎患者具有经济效益。

Noor, Omar; Liu, Jinan; Sturm, Daniel; Ren, Haobo; Paranagama, Dilan; Chiesa Fuxench, Zelma C; Chovatiya, Raj

A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease

一项随机、双盲、安慰剂对照临床试验,旨在评估 Liv-Pro(一种用于治疗非酒精性脂肪肝的食品补充剂)的效果。

Kuruppu, Anchala Ishani; Liyanage, Uditha Prabhath; Chamika, Aruni; Paranagama, Priyani Asoka; Hettigoda, Lankani

Elucidating the potential of Annona muricata L. grown in Sri Lanka to be used in developing an anticancer drug against colorectal and breast cancers

阐明斯里兰卡种植的刺果番荔枝(Annona muricata L.)在开发抗结直肠癌和乳腺癌药物方面的潜力

Pathirana, Onela Canith; Paranagama, Madhavi Priyanka; Wijesundera, Kavindra Kumara; Mahakapuge, Thilini Anupama Nanayakkarawasam; Abeykoon, Abeykoon Mudiyanselage Anuththara Upamali; Rajapakse, Jayantha

Wood decay fungi show enhanced biodeterioration of low-density polyethylene in the absence of wood in culture media

在培养基中不含木材的情况下,木腐菌对低密度聚乙烯的生物降解作用增强。

Perera, Prameesha; Herath, Harshini; Paranagama, Priyani A; Wijesinghe, Priyanga; Attanayake, Renuka N

Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study

真性红细胞增多症患者服用阿司匹林联合抗凝剂治疗期间出血:一项前瞻性观察研究

Zwicker, Jeffrey I; Paranagama, Dilan; Lessen, David S; Colucci, Philomena M; Grunwald, Michael R

Cytotoxic Bioxanthracene and Macrocyclic Polyester from Endolichenic Fungus Talaromyces pinophilus: In-Vitro and In-Silico Analysis

内生真菌Talaromyces pinophilus中的细胞毒性生物黄蒽和大环聚酯:体外和硅基分析

Chaitrali Shevkar #, Ashwini Armarkar #, Ramani Weerasinghe, Kasun Maduranga, Komal Pandey, Santosh K Behera, Kiran Kalia, Priyani Paranagama, Abhijeet S Kate

Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes

鲁索替尼再治疗骨髓纤维化患者:患者特征和结局的真实世界证据

Gerds, Aaron T; Yu, Jingbo; Scherber, Robyn M; Paranagama, Dilan; Kish, Jonathan K; Visaria, Jay; Singhal, Mukul; Verstovsek, Srdan; Pemmaraju, Naveen

Antimicrobial Compounds Isolated from Endolichenic Fungi: A Review

从地衣真菌中分离的抗菌化合物:综述

Wethalawe, A Nethma; Alwis, Y Vindula; Udukala, Dinusha N; Paranagama, Priyani A

Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States

美国社区肿瘤诊所中骨髓纤维化患者的真实世界风险评估和治疗启动

Verstovsek, Srdan; Yu, Jingbo; Kish, Jonathan K; Paranagama, Dilan; Kaufman, Jill; Myerscough, Callan; Grunwald, Michael R; Colucci, Philomena; Mesa, Ruben

Structure-based design of guanosine analogue inhibitors targeting GTP cyclohydrolase IB towards a new class of antibiotics

基于结构的鸟苷类似物抑制剂设计,靶向GTP环化水解酶IB,旨在开发一类新型抗生素

Samaan, George N; Paranagama, Naduni; Haque, Ayesha; Hecht, David A; Swairjo, Manal A; Purse, Byron W